Global phylogenomic insights into the evolutionary adaptation of Helicobacter pylori: evidence from 1467 isolates and the fixation of cage D792 mutation
Shenke Zhang , Lianghui Peng , Boyu Liao , Cuixian Yang , Jingjie Song , Zeeshan Umar , Shengli Zhang , Liqiu Ma , Rui Liu
Genome Instability & Disease ›› 2025, Vol. 7 ›› Issue (1) : 3
Global phylogenomic insights into the evolutionary adaptation of Helicobacter pylori: evidence from 1467 isolates and the fixation of cage D792 mutation
Helicobacter pylori (H. pylori) is a globally prevalent gastric pathogen with substantial genetic diversity shaped by human co-evolution. Although extensive research has been conducted on H. pylori, the mechanisms underlying its adaptation and virulence remain incompletely understood. Here, we performed a phylogenomic analysis of 1467 isolates from 26 countries by constructing a core-genome single-nucleotide polymorphism (SNP) phylogeny and analyzing population structure, revealing five major lineages with distinct regional adaptations. A genome-wide Fixation Index (Fst) analysis identified 20 highly differentiated genes, with cagE (Fst = 0.8041)—a key component of the Type IV Secretion System (T4SS)—showing the strongest signal of positive selection. We discovered a novel N792D mutation in cagE, fixed in cluster c1, particularly in North America, which may enhance immune evasion and promote persistent colonization. Bayesian Evolutionary Analysis Sampling Trees 2 (BEAST2) analysis estimated that the most recent common ancestor (tMRCA) of highly virulent H. pylori emerged around 1934 (95% HPD: 1933–1934), coinciding with global conflicts and migrations that likely facilitated its spread. This study provides new insights into H. pylori evolution, highlighting the cagE mutation as a potential therapeutic target.
Helicobacter pylori evolution / Phylogenomic / cagE D792 mutation / Adaptive evolution
| [1] |
|
| [2] |
Barrozo, R. M., Hansen, L. M., Lam, A. M., Skoog, E. C., Martin, M. E., Cai, L. P., et al. (2016). CagY is an immune-sensitive regulator of the Helicobacter pylori type IV secretion system. Gastroenterology. https://doi.org/10.1053/j.gastro.2016.08.014 |
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Bush, S. J. (2021). Generalizable characteristics of false-positive bacterial variant calls. Microbial Genomics, 7(8). https://doi.org/10.1099/mgen.0.000615 |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
Ghazanfar, H., Javed, N., Reina, R., Thartori, O., Ghazanfar, A., & Patel, H. (2024). Advances in diagnostic modalities for Helicobacter pylori infection. Life (Basel). https://doi.org/10.3390/life14091170 |
| [20] |
Giorgi, F. M., Ceraolo, C., & Mercatelli, D. (2022). The R language: An engine for bioinformatics and data science. Life (Basel Switzerland). https://doi.org/10.3390/life12050648 |
| [21] |
Gómez-Rubio, V. (2017). ggplot2 - Elegant graphics for data analysis (2nd edition). Journal of Statistical Software, Book Reviews, 77(2), 1–3. https://doi.org/10.18637/jss.v077.b02 |
| [22] |
|
| [23] |
|
| [24] |
Helfrich, P., Rieb, E., Abrami, G., Lücking, A., & Mehler, A. (2018). TreeAnnotator: Versatile visual annotation of hierarchical text relations. |
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
Kumar, S., Metz, D. C., Ellenberg, S., Kaplan, D. E., & Goldberg, D. S. (2020). Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: A large cohort study. Gastroenterology. https://doi.org/10.1053/j.gastro.2019.10.019 |
| [33] |
|
| [34] |
Lin, A. S., Dooyema, S. D. R., Frick-Cheng, A. E., Harvey, M. L., Suarez, G., Loh, J. T., et al. (2020). Bacterial energetic requirements for Helicobacter pylori Cag type IV secretion system-dependent alterations in gastric epithelial cells. Infection and Immunity. https://doi.org/10.1128/IAI.00790-19 |
| [35] |
|
| [36] |
Mladenova, I. (2021). Clinical relevance of Helicobacter pylori infection. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10163473 |
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
Shenzhen University School of Medicine; Fondazione Istituto FIRC di Oncologia Molecolare
/
| 〈 |
|
〉 |